ストックスクリーナーアプリを入手
92.20
2.27%
-2.14
前日終値:
$94.34
開ける：
$93.33
24時間の取引高:
515.42K
Relative Volume:
0.54
時価総額：
$2.90B
収益：
$267.23M
当期純損益:
$-83.50M
株価収益率:
-29.65
EPS:
-3.11
ネットキャッシュフロー:
$-59.99M
1週間 パフォーマンス:
-11.68%
1か月 パフォーマンス:
-8.71%
6か月 パフォーマンス:
+115.47%
1年 パフォーマンス:
+909.86%
1日の値動き範囲:
$89.52
$94.23
1週間の範囲:
$89.52
$107.98
52週間の値動き範囲:
$8.53
$115.60
Genedx Holdings Corp Stock (WGS) Company Profile
WGS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
92.20 | 2.90B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-07-10 | 開始されました | Craig Hallum | Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
Genedx Holdings Corp (WGS) 最新ニュース
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock - Investing.com India
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock By Investing.com - Investing.com South Africa
GeneDx CEO Stueland sells $4.45 million in stock - Investing.com
GeneDx Holdings Corp. Executives Sell Shares to Cover Tax Obligations - TradingView
7 Up-and-Coming Stocks to Buy in 2025 - U.S News & World Report Money
How To Trade (WGS) - Stock Traders Daily
3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2% - Simply Wall St
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now? - Insider Monkey
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -March 20, 2025 at 04:52 pm EDT - Marketscreener.com
GeneDx Strengthens Team: 10 New Hires Receive Strategic Stock Awards Worth 46,340 RSUs - StockTitan
Zacks.com featured highlights DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba - Yahoo Finance
12 High Growth Low Debt Stocks to Invest in Now - Insider Monkey
Is Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)? - Yahoo Finance
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies - Yahoo Finance
GeneDx Revolutionizes Genome Sequencing with 48-Hour Results, Earns Top Innovation Honor - StockTitan
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
Is GeneDx Holdings (NASDAQ:WGS) Using Too Much Debt? - Simply Wall St
Raymond James Financial Inc. Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
3,501 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Arizona State Retirement System - Defense World
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Short Interest in GeneDx Holdings Corp. (NASDAQ:WGSWW) Drops By 43.2% - Defense World
Is GeneDx Holdings Corp. (WGS) the Best Multibagger Stock to Buy in 2025? - Insider Monkey
Revolutionary AI Tool by GeneDx Transforms Genetic Testing with 750,000 Clinical Sequences - StockTitan
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting - Yahoo Finance
GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich (NASDAQ:WGS) - Seeking Alpha
Genedx CFO Kevin Feeley sells shares worth $87k By Investing.com - Investing.com Australia
GeneDx CEO Katherine Stueland sells $258,695 in company stock By Investing.com - Investing.com South Africa
12 Best Multibagger Stocks to Buy in 2025 - Insider Monkey
Genedx CFO Kevin Feeley sells shares worth $87k - Investing.com
GeneDx CEO Katherine Stueland sells $258,695 in company stock - Investing.com
Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now? - Insider Monkey
10 Best Emerging Technology Stocks to Buy Now - Insider Monkey
Lisanti Capital Growth LLC Raises Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics By Investing.com - Investing.com South Africa
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics - Investing.com India
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Principal Financial Group Inc. - Defense World
Rhumbline Advisers Buys 1,021 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Shares Surge Amid Strong Prospects - TipRanks
GeneDx Expanding Genetic Testing to Include Cerebral Palsy -March 04, 2025 at 09:53 am EST - Marketscreener.com
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Sees Significant Increase in Short Interest - Defense World
GeneDx Holdings Corp. (NASDAQ:WGSWW) Short Interest Update - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings CorpWGS - PR Newswire
An Investigation Has Commenced on Behalf of GeneDx Holdings Corp. Shareholders. Contact Levi & Korsinsky to Discuss your WGS Losses. - ACCESS Newswire
GeneDx Holdings Corp. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsWGS - ACCESS Newswire
New York State Common Retirement Fund Buys 52,843 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Why Investors Shouldn't Be Surprised By GeneDx Holdings Corp.'s (NASDAQ:WGS) 32% Share Price Surge - Simply Wall St
Nasdaq Cedes Big Gain On Tariff Jitters; GeneDx, Atlassian, Duolingo In FocusVideoIBD - Investor's Business Daily
GeneDx Holdings Corp (NASDAQ: WGS) 0.89% Incline Turns Investors Away - Stocks Register
GeneDx Holdings Stock Soars on Strong Earnings - TipRanks
GeneDx Holdings Corp.: A Comprehensive Analysis - HPBL
Genedx Holdings Corp (WGS) 財務データ
収益
当期純利益
現金流量
EPS
Genedx Holdings Corp (WGS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 26 '25 |
Sale |
95.61 |
8,746 |
836,211 |
15,996 |
| Stueland Katherine | Chief Executive Officer |
Mar 26 '25 |
Option Exercise |
0.00 |
80,000 |
0 |
94,865 |
| Stueland Katherine | Chief Executive Officer |
Mar 26 '25 |
Sale |
95.62 |
46,551 |
4,451,084 |
48,314 |
0.80%
0.71%
大文字化:
|
ボリューム (24 時間):